143 related articles for article (PubMed ID: 11526904)
1. Vaccine passes another test.
AIDS Patient Care STDS; 2001 Jul; 15(7):404. PubMed ID: 11526904
[No Abstract] [Full Text] [Related]
2. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
[No Abstract] [Full Text] [Related]
3. HIV vaccines. Viral envelope fails to deliver?
Bolognesi DP; Matthews TJ
Nature; 1998 Feb; 391(6668):638-9. PubMed ID: 9490406
[No Abstract] [Full Text] [Related]
4. Large HIV vaccine trial begins.
Santiago L
GMHC Treat Issues; 1998 Oct; 12(10):1-5. PubMed ID: 11365900
[TBL] [Abstract][Full Text] [Related]
5. Controversial HIV vaccine enters phase III trials amid skepticism.
AIDS Alert; 1998 Dec; 13(12):133-4, 136. PubMed ID: 11366059
[TBL] [Abstract][Full Text] [Related]
6. US and Thai Governments defend HIV/AIDS vaccine trial in Thailand.
Agnew B
Bull World Health Organ; 2004 Mar; 82(3):231. PubMed ID: 15112014
[No Abstract] [Full Text] [Related]
7. Lessons from failure--preparing for future HIV-1 vaccine efficacy trials.
Graham BS; Mascola JR
J Infect Dis; 2005 Mar; 191(5):647-9. PubMed ID: 15688276
[No Abstract] [Full Text] [Related]
8. First AIDS vaccine trial launched.
Science; 1998 Jun; 280(5370):1697. PubMed ID: 9660708
[No Abstract] [Full Text] [Related]
9. Virology. Moving forward in HIV vaccine development.
Letvin NL
Science; 2009 Nov; 326(5957):1196-8. PubMed ID: 19965456
[No Abstract] [Full Text] [Related]
10. Funding support lacking in search for HIV vaccine.
AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091
[TBL] [Abstract][Full Text] [Related]
11. Building and testing an effective HIV vaccine.
Kahn J
West J Med; 1999; 171(5-6):363-5. PubMed ID: 10639877
[No Abstract] [Full Text] [Related]
12. Outstanding questions on HIV vaccine trial.
Jefferys R; Harrington M
Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456
[No Abstract] [Full Text] [Related]
13. Support for the RV144 HIV vaccine trial.
AIDS Vaccine Advocacy Coalition
Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15250069
[No Abstract] [Full Text] [Related]
14. Support for the RV144 HIV vaccine trial.
Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M
Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455
[No Abstract] [Full Text] [Related]
15. Army HIV vaccine to undergo clinical trial as rival is halted.
Check E
Nature; 2002 Mar; 416(6876):6. PubMed ID: 11882860
[No Abstract] [Full Text] [Related]
16. HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand.
Rerks-Ngarm S; Brown AE; Khamboonruang C; Thongcharoen P; Kunasol P
AIDS; 2006 Jul; 20(11):1471-9. PubMed ID: 16847401
[No Abstract] [Full Text] [Related]
17. Thai HIV vaccine trial prompts angry exchanges.
Nelson K
Lancet; 2004 Jan; 363(9405):299. PubMed ID: 14753209
[No Abstract] [Full Text] [Related]
18. Policy rebuttal. HIV vaccine trial justified.
McNeil JG; Johnston MI; Birx DL; Tramont EC
Science; 2004 Feb; 303(5660):961. PubMed ID: 14963313
[No Abstract] [Full Text] [Related]
19. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
20. NIAID collaborates with VaxGen on vaccine studies.
AIDS Patient Care STDS; 1998 Nov; 12(11):874. PubMed ID: 11362049
[No Abstract] [Full Text] [Related]
[Next] [New Search]